166 related articles for article (PubMed ID: 20618995)
21. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.
Cárdenas AM; González-Jamett AM; Cea LA; Bevilacqua JA; Caviedes P
Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407
[TBL] [Abstract][Full Text] [Related]
22. Late onset in dysferlinopathy widens the clinical spectrum.
Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
[TBL] [Abstract][Full Text] [Related]
23. Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency.
Selva-O'Callaghan A; Labrador-Horrillo M; Gallardo E; Herruzo A; Grau-Junyent JM; Vilardell-Tarres M
Neuromuscul Disord; 2006 Mar; 16(3):208-9. PubMed ID: 16483775
[TBL] [Abstract][Full Text] [Related]
24. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723
[TBL] [Abstract][Full Text] [Related]
26. Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.
Nalotto L; Iaccarino L; Zen M; Gatto M; Borella E; Domenighetti M; Punzi L; Doria A
Immunol Res; 2013 Jul; 56(2-3):362-70. PubMed ID: 23572427
[TBL] [Abstract][Full Text] [Related]
27. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
Chase TH; Cox GA; Burzenski L; Foreman O; Shultz LD
Am J Pathol; 2009 Dec; 175(6):2299-308. PubMed ID: 19875504
[TBL] [Abstract][Full Text] [Related]
28. Rituximab mediates loss of CD19 on B cells in the absence of cell death.
Jones JD; Hamilton BJ; Rigby WF
Arthritis Rheum; 2012 Oct; 64(10):3111-8. PubMed ID: 22674374
[TBL] [Abstract][Full Text] [Related]
29. Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis.
Roll P; Mahmood Z; Muhammad K; Feuchtenberger M; Dörner T; Tony HP
Clin Exp Rheumatol; 2015; 33(3):347-53. PubMed ID: 25897997
[TBL] [Abstract][Full Text] [Related]
30. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.
Williams ME; Densmore JJ; Pawluczkowycz AW; Beum PV; Kennedy AD; Lindorfer MA; Hamil SH; Eggleton JC; Taylor RP
J Immunol; 2006 Nov; 177(10):7435-43. PubMed ID: 17082663
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis.
Angelini C; Grisold W; Nigro V
Acta Myol; 2011 Dec; 30(3):185-7. PubMed ID: 22616201
[TBL] [Abstract][Full Text] [Related]
32. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
[TBL] [Abstract][Full Text] [Related]
33. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
[TBL] [Abstract][Full Text] [Related]
34. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
Ho M; Gallardo E; McKenna-Yasek D; De Luna N; Illa I; Brown RH
Ann Neurol; 2002 Jan; 51(1):129-33. PubMed ID: 11782994
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J; Du J; Wang S; Xiao L; Zhao X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[TBL] [Abstract][Full Text] [Related]
36. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
[TBL] [Abstract][Full Text] [Related]
37. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.
McNally EM; Ly CT; Rosenmann H; Mitrani Rosenbaum S; Jiang W; Anderson LV; Soffer D; Argov Z
Am J Med Genet; 2000 Apr; 91(4):305-12. PubMed ID: 10766988
[TBL] [Abstract][Full Text] [Related]
38. Induction of interleukin-6 production by rituximab in human B cells.
Jones JD; Hamilton BJ; Skopelja S; Rigby WF
Arthritis Rheumatol; 2014 Nov; 66(11):2938-46. PubMed ID: 25080282
[TBL] [Abstract][Full Text] [Related]
39. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
[TBL] [Abstract][Full Text] [Related]
40. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
